Ignite Creation Date:
2024-05-06 @ 12:35 PM
Last Modification Date:
2024-10-26 @ 1:01 PM
Study NCT ID:
NCT03794518
Status:
UNKNOWN
Last Update Posted:
2019-01-07
First Post:
2018-08-01
Brief Title:
Effect of Dapagliflozin Plus Low Dose Pioglitazone on Hospitalization Rate in Patients With HF and HFpEF
Sponsor:
Hamad Medical Corporation
Organization:
Hamad Medical Corporation
Organization Data
Organization:
Hamad Medical Corporation
Class:
INDUSTRY
Study ID:
IRGC-04-SI-17-116
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hamad Medical Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None